Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 26.61
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Trimurthi Ltd. operates as a holding company, which engages in the distribution, retail, and marketing of pharmaceutical products. It operates through the following business segments: Pharma Business, Financial Activity, Investment Activity, and Trading in Shares. Its products include medicine for contraception, obstetrics and gynecology, digestive system, and other areas. The company was founded in December 13, 1994 and is headquartered in Hyderabad, India.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI
Data is available to registered users only
Buy
Sell